Question 1

Who are the top researchers at TechnoVax (United States)?

Accepted Answer

Ranked on the quality score, Jose M. Galarza lead among researchers whose main affiliation is TechnoVax (United States).

Question 2

What are the most cited papers from TechnoVax (United States)?

Accepted Answer

The most cited paper from TechnoVax (United States) is "Zika virus-like particle (VLP) based vaccine" (Hélène Boigard, Alexandra Alimova, George R. Martin et al., 2017), with 162 citations. Next come "Adjuvant formulations for virus-like particle (VLP) based vaccines" (145) and "A Novel Intranasal Virus-Like Particle (VLP) Vaccine Designed to Protect against the Pandemic 1918 Influenza A Virus (H1N1)" (59).

Question 3

Which research topics does TechnoVax (United States) publish most on?

Accepted Answer

By volume in 2022-now: Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects, CRISPR and Genetic Engineering and Viral gastroenteritis research and epidemiology.

Question 4

Which fields of science does TechnoVax (United States) work in?

Accepted Answer

In all years, 63% of research at TechnoVax (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (23%), Agricultural and Biological Sciences (7%). It does 1.5× the world's share of Health Sciences.

Question 5

Is TechnoVax (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 39% higher than in 2018-2021.